Aug 8, 2018
Our team has significant ophthalmic drug development experience and deep relationships with global ophthalmology thought leaders. We have an extensive
seen from Germany
seen from China
seen from Netherlands
seen from Russia
seen from China
seen from Spain
seen from United Kingdom
seen from Germany
seen from United States
seen from United States
seen from Malaysia
seen from United Kingdom
seen from Malaysia
seen from Hong Kong SAR China
seen from Poland
seen from Portugal
seen from China
seen from Poland
seen from China
seen from United Kingdom
Our team has significant ophthalmic drug development experience and deep relationships with global ophthalmology thought leaders. We have an extensive
Ophthotech Corp (NASDAQ:OPHT)
On Wednesday, Shares of Ophthotech Corp(NASDAQ:OPHT), gain 0.02% and opened at $55.79 with the market capitalization of 1.95B.As Ophthotech declared 1st Patient Dosed in Zimura Phase two-third Study to Evaluate cure in Patients with Geographic Atrophy, a superior Form of Dry Age-Related Macular Degeneration.
The shares of Ophthotech Corp (NASDAQ:OPHT) is trading in the range of $55.52 to…
View On WordPress